title: [Fatal subfulminant hepatitis caused by cyproterone acetate].
authors.forename: M
authors.initials: M
authors.lastname: Antoni
authors.forename: M
authors.initials: M
authors.lastname: Bourlière
authors.forename: J
authors.initials: J
authors.lastname: Toullec
authors.forename: A
authors.initials: A
authors.lastname: Maillot
authors.forename: D
authors.initials: D
authors.lastname: Botta-Fridlund
authors.forename: A
authors.initials: A
authors.lastname: Gauthier
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000506:poisoning; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000401:mortality; D003534:Cyproterone / Q000031:analogs & derivatives* / Q000506:poisoning / Q000627:therapeutic use; D017373:Cyproterone Acetate; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D017373:Cyproterone Acetate; D003534:Cyproterone
vernacular_title: Hépatite sub-fulminante d'évolution mortelle à l'acétate de cyprotérone.